Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2010

Open Access 01-12-2010 | Review

5thInternational AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - Introduction

Author: Rodney Kort

Published in: Journal of the International AIDS Society | Special Issue 1/2010

Login to get access

Excerpt

Attracting more than 5800 participants from 123 countries, the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009), held in Cape Town, South Africa, on 19-23 July 2009, offered more than 1550 reports on original research in four areas: basic sciences (Track A), clinical sciences (Track B), biomedical prevention (Track C), and – new at this meeting – operations research (Track D). The 59 sessions included 12 plenary addresses by leaders from every area of HIV research. The conference was particularly rich in research that may affect the path of the epidemic in low- and middle-income countries, although policy- and practice-shaping developments from high-income countries were also present. …
Metadata
Title
5thInternational AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - Introduction
Author
Rodney Kort
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S1-S1

Other articles of this Special Issue 1/2010

Journal of the International AIDS Society 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine